Regional Analysis Of A Cohort Compassionate-Use Program And Early Access Program With Cabazitaxel Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated With Docetaxel

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY(2015)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要